Results 141 to 150 of about 6,476,358 (258)

Post-exposure prophylaxis with antibiotics to prevent sexually transmitted infections. [PDF]

open access: yesCochrane Database Syst Rev
Shibutani K   +5 more
europepmc   +1 more source

HIV Pre-Exposure Prophylaxis: Statewide Plan and Guidance

open access: yes
The South Carolina Department of Health and Environmental Control (DHEC) HIV Pre-exposure Prophylaxis (PrEP) Statewide Plan and Guidance has been developed by DHEC as an element of the PrEPMeSC initiative.
Department of Health and Environmental Control. Division of STD/HIV and Viral Hepatitis
core  

Baseline Body Mass Index Category and Incident Treated Hypertension in Australian Men: A Linked Prospective Cohort Study Using PBS/MBS Data

open access: yesChronic Diseases and Translational Medicine, EarlyView.
Kaplan–Meier hypertension‐free survival by baseline body mass index category, primary adult cohort (men aged ≥ 18 years, n = 12,742). Time since baseline in years is plotted on the horizontal axis and the probability of remaining free of treated hypertension is plotted on the vertical axis. Numbers at risk are shown beneath the plot.
Ebenezer Afrifa‐Yamoah
wiley   +1 more source

Nationwide registry-based analysis of rabies exposures in Iran: Epidemiological patterns and post-exposure prophylaxis adherence. [PDF]

open access: yesPLoS Negl Trop Dis
Babaee E   +6 more
europepmc   +1 more source

Viral Dynamic Model‐Informed Dose Selection of Mosnodenvir Prophylaxis against DENV‐3 in a Controlled Human Infection Model

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Dengue virus (DENV) infection is a significant global health threat. Mosnodenvir (JNJ‐64281802) is a pan‐serotype small molecule antiviral blocking DENV replication. A Phase IIa study (NCT05048875) evaluated the antiviral activity, safety, and pharmacokinetics of mosnodenvir as prophylaxis against DENV‐3 in a controlled human infection model (CHIM).
Nele Goeyvaerts   +8 more
wiley   +1 more source

A glance at rabies pre-exposure and post-exposure prophylaxis for dog bites

open access: yes
Pre-exposure prophylaxis (PrEP) has a role in decreasing the need for immunoglobulin injection, because the real problems with post-exposure prophylaxis (PEP) are the cost of the vaccine and immunoglobulin, as well as the availability of the ...
Antonino Appignani   +3 more
core   +1 more source

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian   +5 more
wiley   +1 more source

Rabies viral RNA and antibody response after post-exposure prophylaxis: Implications for blood donor deferral. [PDF]

open access: yesTrop Dis Travel Med Vaccines
Singh AD   +8 more
europepmc   +1 more source

Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavir

open access: yes
The persistent global burden of HIV and the need for more flexible, durable prevention strategies have accelerated the development of long-acting pre-exposure prophylaxis (PrEP) options.
Sarah L Anderson, Anderson, Sarah L
core   +1 more source

Home - About - Disclaimer - Privacy